Cue Biopharma (CUE) Operating Margin (2018 - 2025)
Historic Operating Margin for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 353.42%.
- Cue Biopharma's Operating Margin fell 891800.0% to 353.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 537.49%, marking a year-over-year decrease of 580800.0%. This contributed to the annual value of 446.86% for FY2024, which is 5030300.0% up from last year.
- As of Q3 2025, Cue Biopharma's Operating Margin stood at 353.42%, which was down 891800.0% from 292.32% recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Operating Margin registered a high of 95.62% during Q4 2021, and its lowest value of 50346.15% during Q2 2022.
- For the 5-year period, Cue Biopharma's Operating Margin averaged around 4982.42%, with its median value being 737.8% (2024).
- In the last 5 years, Cue Biopharma's Operating Margin plummeted by -499699900bps in 2022 and then skyrocketed by 493680800bps in 2023.
- Cue Biopharma's Operating Margin (Quarter) stood at 95.62% in 2021, then tumbled by -10196bps to 9845.03% in 2022, then soared by 92bps to 759.58% in 2023, then rose by 20bps to 611.23% in 2024, then skyrocketed by 42bps to 353.42% in 2025.
- Its Operating Margin stands at 353.42% for Q3 2025, versus 292.32% for Q2 2025 and 2921.38% for Q1 2025.